United Kingdom · Question · Written question
UIN 59501
Muscular Dystrophy: Medical Treatments
Introduced
10 October 2022
Last action
19 October 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
19 October 2022
Summary
To ask the Secretary of State for Health and Social Care, for what reason people with muscular dystrophy LGMD-E2 are not entitled to antiviral treatment under the Government’s antiviral treatments protocol.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 October 2022
Written question
To ask the Secretary of State for Health and Social Care, for what reason people with muscular dystrophy LGMD-E2 are not entitled to antiviral treatment under the Government’s antiviral treatments protocol.
Source: Commons
19 October 2022
Answer
Clinically eligible cohorts have been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the United Kingdom Chief Medical Officers. The cohorts include patients whose immune systems mean th...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-10-10/59501
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1519233
- uk · wq-1519233 · source updated 19 October 2022